Ledger.Open graph →
SEC Form D · filed November 12, 2014

Metheor Therapeutics Corp

Offering
$200K
Sold
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SHORELINE, WA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Theo Z. Devos · Shoreline, WAExecRobert Z. Day · Shoreline, WADirectorAndrew Z. Sledziewski · Shoreline, WAExec · DirectorBruce L. Carter · Shoreline, WADirectorGary Z. Schweikhardt · Shoreline, WADirectorJawad Rahimi · Pittsburgh, PAExec · DirectorGarrett M. Potter · Escondido, CAExecChristina Koshzow · Pittsburgh, PADirectorGary Wishnatzki · Plant City, FLDirectorJoel Sussman · Malvern, PADirectorTrishield Capital Management LLC · New York, NYDirectorTrishield Partners LLC · New York, NYDirectorPeter B. Clark · London, United KingdomExecPatrick Gallagher · Pittsburgh, PAExec · DirectorM. Steven F. Langman · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗